"Neuroscience: Dealing With Frontiers" ed. by Carlos M. Contreras (repost)

The chapters contained in this book illustrate that neuroscience converges in the search for sound answers to several questions, including the pathways followed by cells, how individuals communicate with each other, inflammation, learning and memory, the development of drug dependence, and approaches to explaining the processes that underlie two highly incapacitating chronic degenerative illnesses.

The Neuronal Doctrine recently reached its 100th year and together with the development of psychopharmacology by the middle of 20th century promoted spectacular developments in the knowledge of the biological bases of behavior.
The overwhelming amount of data accumulated, forced the division of neuroscience into several subdisciplines, but this division needs to dissolve in the 21st century and focus on specific processes that involve diverse methodological and theoretical approaches.

Contents
Preface
1 Adrenaline and Noradrenaline: Partners and Actors in the Same Play
2 The Mystery of P2X7 lonotropic Receptor: From a Small Conductance Channel to a Large Conductance Channel
3 Facilitation of Neurotransmitter and Hormone Release by P2X Purinergic Receptors
4 Assessment of Brain Monoaminergic Signaling Through Mathematical Modeling of Skin Conductance Response
5 Fatty Acids and Emotional Behavior
6 Transforming Growth Factor Beta in the Central Nervous System
7 Neurochemistry in the Pathophysiology of Septic Encephalopathy
8 The Neurochemical Anatomy of Trigeminal Primary Afferent Neuronsv
9 р-Endorphin and Alcoholism
10 The Role of Delta Opioid Receptors in Ethanol Consumption and Seeking: Implications for New Treatments for Alcohol Use Disorders
11 Normal and Physio-Pathological Striatal Dopamine Homeostasis
12 Activity-Dependent Regulation of the Dopamine Phenotype in the Adult Substantia Nigra: Prospects for Treating Parkinson's Disease
13 Molecular Mechanisms in Synaptic Plasticity
14 Brain Energy Metabolism in Health and Disease
15 Tau and Amyloid-p Conformational Change to p-Sheet Structures as Effectors in the Development of Alzheimer's Disease
16 Alzheimer's Disease: Approaches to Pathogenesis in the Genomic Age



More : You find here